Integrated Strategies for Advancing CNS Drug Development
CNS drug development remains one of the most complex challenges in biopharmaceutical research—from target validation and brain exposure to translational predictability and safety assessment.
In this webinar, experts in CNS discovery, translational pharmacology, DMPK, and non-clinical safety explore how integrated preclinical strategies can inform candidate selection and development decisions.
Watch to gain insights into:
- CNS target validation and translational pharmacology
- Brain exposure, BBB penetration, and translational PK/PD
- Non-clinical safety assessment and candidate advancement
You May Also Be Interested In
Discuss Your Program with Us
Share your development goals and key challenges with our experts to define the right path forward.